Anti-Anginal and Anti-Ischemic Effects of Mibefradil, a New T-Type Calcium Channel Antagonist

Publisher： Karger

E-ISSN： 1421-9751|89|1|23-32

ISSN： 0008-6312

Source： Cardiology, Vol.89, Iss.1, 1998-03, pp. : 23-32

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

STRESS TESTS AND THE EVALUATION OF ANTI‐ANGINAL DRUGS*

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 15, Iss. 10, 1967-10 ,pp. : 908-920

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of expiring reimbursability of pentaerythrityl tetranitrate (PETN, pentalong®) on anti‐anginal therapy: an observational study

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 8, 2015-08 ,pp. : 803-811

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inefficacy of a Highly Selective T‐Type Calcium Channel Blocker in Preventing Atrial Fibrillation Related Remodeling

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 25, Iss. 5, 2014-05 ,pp. : 531-536

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Anti-Ischemic Effect of Metoprolol in Patients with Chronic Angina Pectoris Is Gender-Specific

By  

Cardiology, Vol. 106, Iss. 3, 2006-09 ,pp. : 147-153

Karger

Access to resources Recommend Favorite

P099: Flunarizine, a clinically licensed diphenylmethylpiperazine and T‐type calcium channel inhibitor prevents Hepatitis C virus membrane fusion in a genotype‐dependent manner

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 70-70

John Wiley & Sons Inc

Access to resources Recommend Favorite